Two-year outcomes of leadless vs. transvenous single-chamber ventricular pacemaker in high-risk subgroups

por Boveda, Serge, Higuera, Lucas, Longacre, Colleen, Wolff, Claudia, Wherry, Kael, Stromberg, Kurt, El-Chami, Mikhael F
Publicado 2023

The effectiveness and value of novel treatments for cystic fibrosis: A summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum

por Tice, Jeffrey A, Kuntz, Karen M, Wherry, Kael, Seidner, Matt, Rind, David M, Pearson, Steven D
Publicado 2021

Potential cost savings in the United States from a reduction in sensor-detected severe hypoglycemia among users of the InPen smart insulin pen system

por Chien, Albert, Thanasekaran, Sneha, Gaetano, Angela, Im, Glen, Wherry, Kael, MacLeod, Janice, Vigersky, Robert A
Publicado 2023

Using Medicare Claims to Identify Acute Clinical Events Following Implantation of Leadless Pacemakers

por Wherry, Kael, Stromberg, Kurt, Hinnenthal, Jennifer A, Wallenfelsz, Lisa A, El-Chami, Mikhael F, Bockstedt, Lindsay
Publicado 2020

Implantable cardioverter defibrillator therapy is cost effective for primary prevention patients in Taiwan: An analysis from the Improve SCA trial

por Holbrook, Reece, Higuera, Lucas, Wherry, Kael, Phay, Dave, Hsieh, Yu-Cheng, Lin, Kuo-Hung, Liu, Yen-Bin
Publicado 2020

Contemporaneous Comparison of Outcomes Among Patients Implanted With a Leadless vs Transvenous Single-Chamber Ventricular Pacemaker

por Piccini, Jonathan P., El-Chami, Mikhael, Wherry, Kael, Crossley, George H., Kowal, Robert C., Stromberg, Kurt, Longacre, Colleen, Hinnenthal, Jennifer, Bockstedt, Lindsay
Publicado 2021